Randomized, placebo-controlled trial evaluating the safety of one-year administration of green tea catechins

Although preclinical, epidemiological and prior clinical trial data suggest that green tea catechins (GTCs) may reduce prostate cancer (PCa) risk, several preclinical studies and case reports have reported liver toxicities and acute gastrointestinal bleeding. Based on these observations, regulatory...

Ausführliche Beschreibung